We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
60 hedge funds and large institutions have $218M invested in Rocket Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
24% more capital invested
Capital invested by funds: $175M → $218M (+$42.7M)
13% more funds holding
Funds holding: 53 → 60 (+7)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
60
Holders Change
+7
Holders Change %
+13.21%
% of All Funds
1.57%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
16
Increased
16
Reduced
15
Closed
8
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
+$37K
Top Buyers
Top Sellers
| 1 |
RCP
Rho Capital Partners
New York
|
-$2.65M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.45M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$1.08M |
| 4 |
CCI
Columbus Circle Investors
|
-$798K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$619K |
